1-5 of 5
Terry Furlong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Brief Report
Christopher G. Kanakry, Javier Bolaños-Meade, Yvette L. Kasamon, Marianna Zahurak, Nadira Durakovic, Terry Furlong, Marco Mielcarek, Marta Medeot, Ivana Gojo, B. Douglas Smith, Jennifer A. Kanakry, Ivan M. Borrello, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, William H. Matsui, Lode J. Swinnen, Kenneth R. Cooke, Richard F. Ambinder, Ephraim J. Fuchs, Marcos J. de Lima, Borje S. Andersson, Ravi Varadhan, Paul V. O’Donnell, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2017) 129 (10): 1389–1393.
https://doi.org/10.1182/blood-2016-09-737825
Published: 2017
Includes: Supplemental data
Journal Articles

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

Clinical Trials & Observations
Marco Mielcarek, Terry Furlong, Paul V. O’Donnell, Barry E. Storer, Jeannine S. McCune, Rainer Storb, Paul A. Carpenter, Mary E. D. Flowers, Frederick R. Appelbaum, Paul J. Martin
Journal: Blood
Blood (2016) 127 (11): 1502–1508.
https://doi.org/10.1182/blood-2015-10-672071
Published: 2016
Includes: Supplemental data
Journal Articles

Alpha 1 Anti-Trypsin (AAT) Offers Potent Therapy for Steroid Resistant Gut Gvhd: Interim Results of a Phase I/II Clinical Study

A. Mario Q. Marcondes, MD PhD, Mohamed L. Sorror, MD, Ekapun Karoopongse, MD, Terry Furlong, NP, Marina Lesnikova, PhD, Sabina Janciauskiene, MD, Charles A. Dinarello, MD, H. Joachim Deeg, MD
Journal: Blood
Blood (2014) 124 (21): 3927.
https://doi.org/10.1182/blood.V124.21.3927.3927
Published: 2014
Journal Articles

Post-Transplantation Cyclophosphamide Following Busulfan and Fludarabine Myeloablative Conditioning Prevents Severe Acute and Chronic Graft-Versus-Host Disease and Minimizes Duration Of Immunosuppression: Results Of a Multi-Institutional Trial In Patients With High-Risk Hematologic Malignancies

Christopher G. Kanakry, MD, Paul O’Donnell, MD, PhD, Terry Furlong, NP, Marcos J de Lima, MD, Wei Wei, MS, Marta Medeot, MD, Marco Mielcarek, MD, Richard E Champlin, MD, Richard J. Jones, Peter F. Thall, PhD, Borje S. Andersson, MD, PhD, Leo Luznik
Journal: Blood
Blood (2013) 122 (21): 3310.
https://doi.org/10.1182/blood.V122.21.3310.3310
Published: 2013
Journal Articles

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Clinical Trials & Observations
Marco Mielcarek, Barry E. Storer, Michael Boeckh, Paul A. Carpenter, George B. McDonald, H. Joachim Deeg, Richard A. Nash, Mary E. D. Flowers, Kristine Doney, Stephanie Lee, Kieren A. Marr, Terry Furlong, Rainer Storb, Frederick R. Appelbaum, Paul J. Martin
Journal: Blood
Blood (2009) 113 (13): 2888–2894.
https://doi.org/10.1182/blood-2008-07-168401
Published: 2009
Includes: Supplemental data